Anti-Factor XII heavy chain抗体[B7C9] (ab1007)

概述

  • 产品名称
    Anti-Factor XII heavy chain抗体[B7C9]
    参阅全部 Factor XII heavy chain 一抗
  • 描述
    小鼠单克隆抗体[B7C9] to Factor XII heavy chain
  • 特异性
    This antibody reacts with the heavy chain of human Factor XII (mw~50,000) with a KD of 9.8nM.
  • 经测试应用
    适用于: Other, ELISA, IP, Inhibition Assay, WBmore details
  • 种属反应性
    与反应: Rat, Human
  • 免疫原

    Purified human Factor XII.

  • 表位
    The specific epitope for this antibody is located within a 20 amino acid sequence in the surface binding area of Factor XII.
  • 常规说明

    Abcam is committed to meeting high standards of ethical manufacturing and as such, we will be discontinuing this product, which has been generated by the ascites method, within the next year. We are sorry for any inconvenience this may cause. If you would like help finding an alternative product, please do not hesitate to contact our scientific support team.

性能

  • 形式
    Liquid
  • 存放说明
    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • 存储溶液
    Constituents: PBS, pH 7.2
  • Concentration information loading...
  • 纯度
    Protein G purified
  • 克隆
    单克隆
  • 克隆编号
    B7C9
  • 同种型
    IgG1
  • 研究领域

应用

Our Abpromise guarantee covers the use of ab1007 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
Other Use at an assay dependent concentration.
AP Use at an assay dependent concentration.
ELISA Use at an assay dependent concentration.
IP Use at an assay dependent concentration.
Inhibition Assay Use at an assay dependent concentration.
WB Use at an assay dependent concentration.

Dilute in PBS or medium which is identical to that used in the assay system. This antibody partially blocks Factor XII activity.

靶标

  • 相关性
    Coagulation factor XII circulates in blood as a zymogen. This single chain zymogen is converted to a two chain serine protease with an heavy chain (alpha factor XIIa) and a light chain. The heavy chain contains two fibronectin type domains, two epidermal growth factor (EGF) like domains, a kringle domain and a proline rich domain, whereas the light chain contains only a catalytic domain. On activation, further cleavages takes place in the heavy chain, resulting in the production of beta factor XIIa light chain and the alpha factor XIIa light chain becomes beta factor XIIa heavy chain. Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha factor XIIa and then to beta factor XIIa. The active factor XIIa participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin. It activates coagulation factors VII and XI. Defects in Factor XII gene do not cause any clinical symptoms and the sole effect is that whole blood clotting time is prolonged.
  • 细胞定位
    Secreted
  • 数据库链接
  • 别名
    • Coagulation factor XII antibody
    • Coagulation factor XIIa heavy chain antibody
    • F12 antibody
    • HAE3 antibody
    • HAEX antibody
    • HAF antibody
    • Hageman factor antibody
    see all

Anti-Factor XII heavy chain antibody [B7C9] 图像


  • Developed using the ECL technique

    Performed under reducing conditions.

    Observed band size : 48,70 kDa (why is the actual band size different from the predicted?)


    Exposure time : 2 minutes

    This image is courtesy of an anonymous Abreview

    ab1007 at 1/2000 staining Factror XII heavy chain by Western Blot.

    Lanes 1-6: Human vitreous tissue lysate (2 ug/lane).

    Lane 7: Factor XII

    Lane 8: Factor XIIa.

    A HRP conjugated goat anti-mouse antibody was used as the secondary.

    See Abreview

Anti-Factor XII heavy chain antibody [B7C9] (ab1007)参考文献

This product has been referenced in:
  • Kita T  et al. Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema. Diabetes 64:3588-99 (2015). WB ; Human . Read more (PubMed: 25979073) »
  • von Brühl ML  et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 209:819-35 (2012). Read more (PubMed: 22451716) »

See all 5 Publications for this product

Product Wall

Abcam guarantees this product to work in the species/application used in this Abreview.
Application
Western blot
Sample
Rat Tissue lysate - other (Plasma)
Loading amount
4 µg
Specification
Plasma
Treatment
Kaolin (5mg.ml), Destran (10ug/ml) 37C for 30 min
Gel Running Conditions
Reduced Denaturing
Blocking step
Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Abcam user community

Verified customer

提交于 Jul 26 2007

Abcam guarantees this product to work in the species/application used in this Abreview.
Application
Western blot
Sample
Human Tissue lysate - other (Human)
Loading amount
2 µg
Specification
Human
Blocking step
Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5%
Username

Abcam user community

Verified customer

提交于 Feb 12 2007

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

注册